Serum protein profiling in diffuse large B-cell lymphoma
Purpose The aim of this pilot study was to conduct a nontargeted exploratory proteomics profiling analysis on sera obtained from patients diagnosed with diffuse large B‐cell lymphoma (DLBCL) with the goal of identifying disease‐specific biomarkers. Experimental design Sera from 87 participants (57 c...
Gespeichert in:
Veröffentlicht in: | Proteomics. Clinical applications 2016-11, Vol.10 (11), p.1113-1121 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
The aim of this pilot study was to conduct a nontargeted exploratory proteomics profiling analysis on sera obtained from patients diagnosed with diffuse large B‐cell lymphoma (DLBCL) with the goal of identifying disease‐specific biomarkers.
Experimental design
Sera from 87 participants (57 chemotherapy‐naïve diffuse DLBCL patients, 30 controls frequency‐matched by age group and World Health Organization (WHO) BMI categories) that were part of a large San Francisco Bay Area case‐control study of non‐Hodgkin lymphoma were analyzed by liquid chromatography combined with tandem mass spectrometry.
Results
Thirty‐five proteins (p‐adjusted |
---|---|
ISSN: | 1862-8346 1862-8354 |
DOI: | 10.1002/prca.201600074 |